Finance

Lists
300363:SHE
Porton Pharma Solutions Ltd
CNÂ¥23.91
+0.34%
(+0.080) 1D
Sep 28, 3:04:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300363...
Open
CNÂ¥23.88
High
CNÂ¥24.50
Low
CNÂ¥23.62
Mkt. cap
12.95B
Avg. vol.
27.97M
Volume
16.63M
Dividend
0.38%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
May 12, 2026
52-wk high
CNÂ¥30.40
52-wk low
CNÂ¥13.24
EPS
-CNÂ¥0.28
Shares outstanding
543.44M
No. of employees
4K
Open
CNÂ¥23.88
High
CNÂ¥24.50
Low
CNÂ¥23.62
Mkt. cap
12.95B
Avg. vol.
27.97M
Volume
16.63M
Dividend
0.38%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
May 12, 2026
52-wk high
CNÂ¥30.40
52-wk low
CNÂ¥13.24
EPS
-CNÂ¥0.28
Shares outstanding
543.44M
No. of employees
4K
About Porton Pharma Solutions Ltd
CEO-
Employees4.36K
FoundedJul 7, 2005
Headquarters-
SectorPharmaceutical industry
Websiteporton.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
923.49M
875.40M
886.04M
903.85M
Cost of goods sold
625.73M
614.29M
614.92M
598.01M
Cost of revenue
625.73M
614.29M
614.92M
598.01M
Research and development expenses
82.84M
53.23M
45.16M
60.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
136.88M
167.98M
161.88M
154.77M
Operating expense
236.97M
236.13M
227.23M
210.20M
Total operating expenses
862.70M
850.42M
842.15M
808.22M
Operating income
60.79M
24.98M
43.89M
95.63M
Other non operating income
-12.39M
14.47M
-8.83M
-19.63M
EBT including unusual items
41.17M
20.51M
21.68M
-244.93M
EBT excluding unusual items
51.66M
8.03M
27.51M
89.21M
Income tax expense
11.23M
14.60M
15.37M
16.44M
Effective tax rate
27.27%
71.17%
70.90%
-6.71%
Other operating expenses
3.06M
14.33M
12.69M
1.94M
Net income
52.86M
16.42M
27.87M
-252.07M
Net profit margin
5.72%
1.88%
3.14%
-27.89%
Earnings per share
-
-
-
-
Interest and investment income
501.08K
985.41K
3.18M
13.21M
Interest expense
-13.03M
-8.10M
-10.74M
-
Net interest expenses
-12.53M
-7.12M
-7.55M
13.21M
Depreciation and amortization charges
-
-
-
-
EBITDA
140.76M
113.03M
131.93M
183.10M
Gain or loss from assets sale
-1.06M
1.17M
-
2.63M
AI content may include mistakes. Learn more
Google apps